Successful Treatment of Mycoplasma hominis Meningitis, Diagnosed Using Real-Time Polymerase Chain Reaction, with Ciprofloxacin in a Neonate
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Mycoplasma hominis can cause life-threatening central nervous system infections in neonates following intrauterine infection or during delivery. In newborns, the diagnosis and treatment of M. hominis meningitis are challenging, because cultures are often negative and the bacterium is not susceptible to empirical antibiotics. Herein, we describe a case of neonatal M. hominis meningitis diagnosed using real-time polymerase chain reaction (RT-PCR) and treated with ciprofloxacin. The patient was a 3-day-old female hospitalized for a fever and lethargy. Her blood laboratory findings were non-specific; cerebrospinal fluid (CSF) examination showed a white blood cell count of 580/μL and indicated meningitis. Her symptoms could not be controlled with empirical antibiotics. Urine culture on a special medium revealed ciprofloxacinsusceptible M. hominis. Furthermore, the RT-PCR performed with the CSF sample revealed M. hominis. Therefore, the patient was administered ciprofloxacin; after 2 days, the fever subsided. The patient was discharged on day 30 without complications.
Abstract
Mycoplasma hominis can cause life-threatening central nervous system infections in neonates following intrauterine infection or during delivery. In newborns, the diagnosis and treatment of M. hominis meningitis are challenging, because cultures are often negative and the bacterium is not susceptible to empirical antibiotics. Herein, we describe a case of neonatal M. hominis meningitis diagnosed using real-time polymerase chain reaction (RT-PCR) and treated with ciprofloxacin. The patient was a 3-day-old female hospitalized for a fever and lethargy. Her blood laboratory findings were non-specific; cerebrospinal fluid (CSF) examination showed a white blood cell count of 580/μL and indicated meningitis. Her symptoms could not be controlled with empirical antibiotics. Urine culture on a special medium revealed ciprofloxacinsusceptible M. hominis. Furthermore, the RT-PCR performed with the CSF sample revealed M. hominis. Therefore, the patient was administered ciprofloxacin; after 2 days, the fever subsided. The patient was discharged on day 30 without complications.
참고문헌 (11)
- Wealthall SR, "Mycoplasma meningitis in infants with spina bifida", Dev Med Child Neurol Suppl, 35, pp.117~122 (1975)
- Capoccia R, "Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes", Curr Opin Infect Dis, 26, pp.231~240 (2013)
- Alonso-Vega C, "A fatal case of Mycoplasma hominis meningoencephalitis in a full-term newborn", J Clin Microbiol, 35, pp.286~287 (1997)
- Woo PC, "Then and now : use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories", Clin Microbiol Infect, 14, pp.908~934 (2008)
- Mignard S, "16S rRNA sequencing in routine bacterial identification : a 30-month experiment", J Microbiol Methods, 67, pp.574~581 (2006)
- Safarkar R, "Development a rapid and accurate multiplex real time PCR method for the detection Chlamydia trachomatis and Mycoplasma hominis", J Clin Lab Anal, 31, pp.e22126~ (2017)
- Watt KM, "Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis", Pediatr Infect Dis J, 31, pp.197~199 (2012)
- Hata A, "Mycoplasma hominis meningitis in a neonate : case report and review", J Infect, 57, pp.338~343 (2008)
- Wildenbeest JG, "Neonate with Mycoplasma hominis meningoencephalitis given moxifloxacin", Lancet Infect Dis, 16, pp.e261~e266 (2016)
- Kaguelidou F, "Ciprofloxacin use in neonates : a systematic review of the literature", Pediatr Infect Dis J, 30, pp.e29~e37 (2011)
- Huang YF, "Mycoplasma hominis meningitis in a fullterm neonate : rapid recovery without specific treatment", Indian J Pediatr, 83, pp.1030~1031 (2016)